Announcements Trials
Browse Landscape

Phase

Phase NA 21Phase 4 3Phase 3 3Phase 2 3Phase 1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 1128Carcinoma, Non-Small-Cell Lung 718Neoplasms 545Prostatic Neoplasms 502Colorectal Neoplasms 438Multiple Myeloma 336Lung Neoplasms 309Neoplasm Metastasis 288Leukemia, Myeloid, Acute 263Stomach Neoplasms 248Carcinoma, Hepatocellular 245Ovarian Neoplasms 225Rectal Neoplasms 211Colonic Neoplasms 204Lymphoma, Follicular 200Lymphoma 199Leukemia 190Uterine Cervical Neoplasms 181Head and Neck Neoplasms 174Pancreatic Neoplasms 171Lymphoma, Non-Hodgkin 167Leukemia, Lymphocytic, Chronic, B-Cell 166Lymphoma, Large B-Cell, Diffuse 163Recurrence 161Melanoma 158Precursor Cell Lymphoblastic Leukemia-Lymphoma 154Squamous Cell Carcinoma of Head and Neck 147Pain 141Urinary Bladder Neoplasms 139Brain Neoplasms 133

Interventions

Ralfinamide 1Lidoderm 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Neuroma × Clear all
NCT04115982 2021-08-31

D3NERV

University Hospital, Caen

Phase 3 Unknown
72 enrolled

Neuroma

NCT01019824 2017-09-15

Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

Newron Pharmaceuticals SPA

Phase 3 Completed
411 enrolled

Neuroma, Pain

NCT00266214 2011-06-14

Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome

Endo Pharmaceuticals

Phase 3 Terminated
210 enrolled

Carpal Tunnel Syndrome, Neuroma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡